Subscribe
Tuesday, September 15, 2026
21.6 C
Bengaluru
type here...
Subscribe
Featured ArticleHealthcare News
2 min.Read

GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?

Anup Soans
By Anup Soans

STOP PRESS August 10, 2026: Regulatory Authorisation — The UK Medicines and Healthcare products Regulatory Agency (MHRA) officially approved/authorised orforglipron (Foundayo). August 24, 2026: Commercial Launch — Eli Lilly officially launched the drug in the UK, making it available to patients via private prescriptions. The Real GLP-1 War in India: When the Molecule Becomes a…

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

MedicinMan Pharma Pulse

Medical Reps—Lessons From The West: The Old Model is Dead

0
The Core Conclusion The Western pharma industry is not simply...
Digital in Pharma

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

0
How wearables, diagnostics, AI and continuous monitoring are moving...
Featured Article

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

0
RPG Active Pharma’s agreement to acquire the API and...
Healthcare Ececutive

Pharmacy of the World Pricing Paradox

0
India occupies an extraordinary position in global pharmaceuticals. It...
Featured Article

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

0
India has two very different pharmaceutical regulators living inside...

Topics

MedicinMan Pharma Pulse

Medical Reps—Lessons From The West: The Old Model is Dead

0
The Core Conclusion The Western pharma industry is not simply...
Digital in Pharma

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

0
How wearables, diagnostics, AI and continuous monitoring are moving...
Featured Article

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

0
RPG Active Pharma’s agreement to acquire the API and...
Healthcare Ececutive

Pharmacy of the World Pricing Paradox

0
India occupies an extraordinary position in global pharmaceuticals. It...
Featured Article

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

0
India has two very different pharmaceutical regulators living inside...
MedicinMan Pharma Pulse

MedicinMan Pharma Pulse: August 2026

0
🚀 The Mega-Merger That Wasn't Early August saw the...
Exclusive Report

How To See Dr Reddy’s Nestle In The Wellness Shift

0
GLP-1 medicines such as semaglutide and tirzepatide are changing...
The Pharma Executive

How To Power The India Biopharma Regulatory Revolution Now

0
Beyond the Pharmacy of the World: Why India's Biopharma...
spot_img

Related Articles

spot_imgspot_img
Previous article
How To See Dr Reddy’s Nestle In The Wellness Shift
Next article
MedicinMan Pharma Pulse: August 2026

MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More

Company

Headlines

Medical Reps—Lessons From The West: The Old Model is Dead

0
The Core Conclusion The Western pharma industry is not simply...

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

0
How wearables, diagnostics, AI and continuous monitoring are moving...

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

0
RPG Active Pharma’s agreement to acquire the API and...

Pharmacy of the World Pricing Paradox

0
India occupies an extraordinary position in global pharmaceuticals. It...

Newsletter

Get important news delivered directly to your inbox and stay connected!

Copyright © 2026 | Crafted by SlamDunk